Foreword.
作者信息
Mínguez Beatriz, Lledó-Navarro José Luis
机构信息
Liver Unit, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
出版信息
Clin Drug Investig. 2022 Jun;42(Suppl 1):1-2. doi: 10.1007/s40261-022-01148-4. Epub 2022 May 9.
Abstract
摘要
相似文献
1
Foreword.前言
Clin Drug Investig. 2022 Jun;42(Suppl 1):1-2. doi: 10.1007/s40261-022-01148-4. Epub 2022 May 9.
2
Foreword.前言。
Acta Biomed. 2018 Dec 7;89(7-S):5. doi: 10.23750/abm.v89i7-S.7959.
3
FOREWORD The American Society of Law, Medicine & Ethics and Anti-Racism.前言 美国法律、医学与伦理学会与反种族主义
J Law Med Ethics. 2022;50(1):8-9. doi: 10.1017/jme.2022.2.
4
Foreword to the special issue on applications of atomic force microscopy in cell biology.原子力显微镜在细胞生物学中的应用特刊前言
Semin Cell Dev Biol. 2018 Jan;73:1-3. doi: 10.1016/j.semcdb.2017.06.025. Epub 2017 Jun 30.
5
Immunotherapy Foreword 2018.免疫治疗前言 2018.
Immunotherapy. 2018 Nov;10(16):1339-1341. doi: 10.2217/imt-2018-0183.
6
Foreword: planning for the future through advance directive instruments.前言：通过预先指示工具规划未来。
Psychol Public Policy Law. 1998 Sep;4(3):579-609.
7
Foreword. Special issue: a history of ''lesbian history.''.前言。特刊：“女同性恋史”的历史。
J Lesbian Stud. 2010;14(4):283-7. doi: 10.1080/10894161003682489.
8
Treatment of infectious forms of arthritis. Foreword.感染性关节炎的治疗。前言。
Mod Treat. 1969 Sep;6(5):1067-9.
9
A foreword.前言。
Am J Med. 1970 May;48(5):539-40. doi: 10.1016/0002-9343(70)90001-x.
10
The pathophysiology of hemolytic anemias. A foreword.溶血性贫血的病理生理学。前言。
Am J Med. 1966 Nov;41(5):657-65. doi: 10.1016/0002-9343(66)90028-3.
本文引用的文献
1
Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.肝性脑病与晚期肝病的管理。
Clin Drug Investig. 2022 Jun;42(Suppl 1):5-13. doi: 10.1007/s40261-022-01146-6. Epub 2022 May 10.
2
Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications).晚期肝病（肾功能不全、肝衰竭、肾上腺功能不全、心肺并发症）的肝代偿失调管理。
Clin Drug Investig. 2022 Jun;42(Suppl 1):15-23. doi: 10.1007/s40261-022-01149-3. Epub 2022 May 6.
3
Management of Pharmacologic Adverse Effects in Advanced Liver Disease.晚期肝病中药物不良反应的管理。
Clin Drug Investig. 2022 Jun;42(Suppl 1):33-38. doi: 10.1007/s40261-022-01150-w. Epub 2022 May 6.
4
Nutrition and Chronic Liver Disease.营养与慢性肝病
Clin Drug Investig. 2022 Jun;42(Suppl 1):55-61. doi: 10.1007/s40261-022-01141-x. Epub 2022 Apr 29.
5
Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.慢性肝病晚期肝失代偿的管理：腹水、低钠血症和食管胃静脉曲张出血。
Clin Drug Investig. 2022 Jun;42(Suppl 1):25-31. doi: 10.1007/s40261-022-01147-5. Epub 2022 Apr 27.
6
General Overview About the Current Management of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病现行管理概述。
Clin Drug Investig. 2022 Jun;42(Suppl 1):39-45. doi: 10.1007/s40261-022-01142-w. Epub 2022 Apr 25.
7
Management of Alcohol-Related Liver Disease and Its Complications.酒精性肝病及其并发症的管理。
Clin Drug Investig. 2022 Jun;42(Suppl 1):47-53. doi: 10.1007/s40261-022-01143-9. Epub 2022 Apr 25.
8
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.局部区域治疗在肝癌的分子和免疫治疗时代。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):293-313. doi: 10.1038/s41575-020-00395-0. Epub 2021 Jan 28.
Zotero 插件